Data / Research funding / Food Allergies
Food Allergies: 217 NIH awards ($287.2M) to 67 organizations
217 NIH awards ($287.2M) in the NIH spending category Food Allergies, to 67 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
217 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| New Horizons in the Prevention and Treatment of Food Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $25,961,502 | April 4, 2024 | February 28, 2031 | WOOD, ROBERT A | reporter.nih.gov |
| Systems Biology of Early Atopy (SUNBEAM) Analysis and Bioinformatics Center | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $7,049,932 | December 8, 2022 | November 30, 2028 | BUNYAVANICH, SUPINDA | reporter.nih.gov |
| MIST Early Career Scholar Awards in Mucosal Immunology | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,835,591 | July 25, 2011 | June 30, 2026 | ARTIS, DAVID | reporter.nih.gov |
| The oral environment in food allergy development (ONEIDA) | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $6,732,986 | August 1, 2025 | June 30, 2029 | BUNYAVANICH, SUPINDA | reporter.nih.gov |
| SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $6,503,998 | August 14, 2020 | May 31, 2027 | NADEAU, KARI C. | reporter.nih.gov |
| Food Allergy Management and Outcomes Related to Racial/Ethnic Differences from Infancy through Adolescence: The FORWARD Study | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,583,217 | May 11, 2017 | April 30, 2027 | GUPTA, RUCHI S | reporter.nih.gov |
| Skin microbes and development of allergic disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $5,176,858 | September 5, 2025 | August 31, 2029 | GALLO, RICHARD L | reporter.nih.gov |
| Intervention to Reduce Early (Peanut) Allergy in Children (iREACH) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $4,923,573 | July 24, 2019 | June 30, 2025 | GUPTA, RUCHI S | reporter.nih.gov |
| IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,621,686 | July 1, 1984 | May 31, 2028 | PLATTS-MILLS, THOMAS A. | reporter.nih.gov |
| Comprehensive antigenic mapping of the human anti-peanut IgE antibody response | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,070,467 | December 1, 2020 | November 30, 2025 | SMITH, SCOTT ALAN | reporter.nih.gov |
| B cell memory in human food allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,793,314 | June 9, 2021 | December 31, 2026 | CUROTTO DE LAFAILLE, MARIA A | reporter.nih.gov |
| SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $3,482,713 | August 14, 2020 | January 13, 2023 | NADEAU, KARI C. | reporter.nih.gov |
| Exploiting and enhancing IgE-binding epitopes of the 2S albumins of peanuts and tree nuts | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,375,729 | September 17, 2021 | August 31, 2027 | DRESKIN, STEPHEN C | reporter.nih.gov |
| Defining the impact of type 1 cytokine signaling on STAT-mediated epithelial reprogramming and barrier dysfunction in eosinophilic esophagitis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,375,359 | July 9, 2025 | June 30, 2029 | RUFFNER, MELANIE A | reporter.nih.gov |
| Role of Intestinal Parasites on Regulating Immune Responses to Gut Antigens | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,164,043 | June 22, 2022 | May 31, 2027 | EDELSON, BRIAN TODD | reporter.nih.gov |
| Immune Development Across the Life Course: Integrating Exposures and Multi-Omics in the Boston Birth Cohort | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $3,158,931 | September 15, 2022 | June 30, 2027 | WANG, XIAOBIN | reporter.nih.gov |
| Allergen Loaded Nanoparticles for Food Allergy Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,140,831 | September 16, 2020 | August 31, 2025 | SHEA, LONNIE D | reporter.nih.gov |
| Targeting microbial dysbiosis in Food Allergy to restore tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,989,996 | February 25, 2021 | January 31, 2026 | CHATILA, TALAL AMINE | reporter.nih.gov |
| Mast cell regulation of Th2 induction and tolerance breakdown in food allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,969,900 | July 1, 2015 | November 30, 2026 | OETTGEN, HANS C | reporter.nih.gov |
| Immune Basis of FPIES | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,946,779 | August 23, 2022 | May 31, 2027 | BERIN, CECILIA | reporter.nih.gov |
| Intestinal CD4 T cell responses to dietary and microbial antigens | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,926,273 | January 1, 2013 | December 31, 2026 | MUCIDA, DANIEL S | reporter.nih.gov |
| Anaerobic Manufacturing and Molecular Analytical Process Optimization to Support Clinical Development of Live Biotherapeutic Products | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,921,132 | February 4, 2022 | April 30, 2025 | VALLADARES, RICARDO | reporter.nih.gov |
| Dissecting How Xenobiotics Act as Adjuvants for Oral Allergic Sensitization | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,853,345 | May 24, 2021 | February 1, 2026 | WANG, ANDREW | reporter.nih.gov |
| SUNBEAM Birth Cohort Supplement | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,806,605 | September 6, 2024 | June 30, 2029 | SEIBOLD, MAX A | reporter.nih.gov |
| Mechanisms of Allergen-induced Type 2 Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,733,347 | November 1, 2019 | April 30, 2028 | KITA, HIROHITO | reporter.nih.gov |
| Genetic and Immunological Dissection of Eosinophilic Esophagitis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,674,626 | September 1, 2015 | November 30, 2026 | ROTHENBERG, MARC E. | reporter.nih.gov |
| Understanding alpha-gal red meat allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,615,501 | September 24, 2018 | January 31, 2029 | COMMINS, SCOTT PALMER | reporter.nih.gov |
| Mechanisms for initiation of food allergy early in life | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,583,439 | July 1, 2020 | June 30, 2026 | COOK-MILLS, JOAN M | reporter.nih.gov |
| Immune Mechanisms Regulating Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,540,203 | September 17, 2018 | December 31, 2028 | EISENBARTH, STEPHANIE CAROLINE | reporter.nih.gov |
| Structural and functional characterization of protective antibodies induced in peanut oral immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,498,122 | November 20, 2020 | October 31, 2025 | PATIL, SARITA U | reporter.nih.gov |
| Innovations in Functional B Cell Epitope Discovery for Food Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,431,430 | September 30, 2025 | September 29, 2026 | BOYD, SCOTT | reporter.nih.gov |
| Immunological and Microbial Mechanisms in Food Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,387,215 | November 21, 2016 | January 31, 2028 | CHATILA, TALAL AMINE | reporter.nih.gov |
| Determinants of oral anaphylaxis to food | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,383,525 | September 7, 2023 | August 31, 2027 | WILLIAMS, ADAM | reporter.nih.gov |
| Defining the Role of Immunoglobulin G4 (IgG4) in Food-Induced Eosinophilic Esophagitis (EoE) | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,346,193 | April 4, 2023 | March 31, 2028 | MCGOWAN, EMILY CLARKE | reporter.nih.gov |
| A single cell pooling framework for deciphering the regulatory wiring of allergy in pathophysiologic contexts | NIH | National Human Genome Research Institute | 2021 to 2024 | $2,343,000 | September 23, 2021 | June 30, 2026 | KASOWSKI, MAYA | reporter.nih.gov |
| Mechanisms of enhanced food allergy by S. aureus skin colonization in Atopic Dermatitis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,339,515 | March 22, 2023 | February 29, 2028 | GEHA, RAIF SALIM | reporter.nih.gov |
| Lipid mediated oral tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,327,530 | June 16, 2022 | May 31, 2027 | BALU-IYER, SATHY VENKAT | reporter.nih.gov |
| Affordable Oral Delivery of Human Therapeutic Proteins Bioencapsulated in Plant Cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,264,934 | July 15, 2011 | August 31, 2025 | DANIELL, HENRY | reporter.nih.gov |
| Molecular and cellular mechanisms in food anaphylaxis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,192,068 | June 1, 2020 | May 31, 2025 | GEHA, RAIF SALIM | reporter.nih.gov |
| Maternal influence on offspring food allergy | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,172,334 | September 21, 2022 | July 31, 2027 | OYOSHI, MICHIKO | reporter.nih.gov |
| Antenatal Anxiety and Dyadic Immune Risk(ADIR Study) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,136,482 | June 1, 2023 | May 31, 2028 | OSBORNE, LAUREN M | reporter.nih.gov |
| Vanderbilt University Medical Center (VUMC) CoFAR Clinical Research Center | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,036,652 | March 14, 2024 | February 28, 2031 | BACHARIER, LEONARD B | reporter.nih.gov |
| Scale-up manufacturing of microneedle stamp for peanut allergen immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,994,052 | May 6, 2024 | April 30, 2027 | PATEL, SAMIRKUMAR | reporter.nih.gov |
| Role of the indoor exposome in peanut allergy development | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $1,975,178 | December 22, 2021 | November 30, 2026 | MORAN, TIMOTHY | reporter.nih.gov |
| Mechanism and function of transplacental IgD | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,925,000 | July 9, 2021 | June 30, 2027 | CHEN, KANG | reporter.nih.gov |
| Oral Immunotherapy with IgA to Treat C. difficile Infection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $1,912,856 | April 14, 2022 | March 31, 2025 | SIMON, MICHAEL R | reporter.nih.gov |
| Autophagy and esophageal tissue remodeling in EoE | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,909,099 | September 18, 2017 | April 30, 2026 | NAKAGAWA, HIROSHI | reporter.nih.gov |
| Microneedle Based Targeted Allergen Specific Immunotherapy for Treatment of Peanut Allergies | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,853,276 | April 1, 2019 | April 30, 2024 | PATEL, SAMIRKUMAR | reporter.nih.gov |
| A Community-based Assessment of Skin Care, Allergies, and Eczema: The CASCADE Trial | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,840,538 | April 1, 2018 | February 28, 2025 | SIMPSON, ERIC L | reporter.nih.gov |
| The role of peripheral immune cell activity in food-allergy-induced neuroinflammation and demyelination | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,816,907 | April 18, 2022 | March 31, 2027 | NAGAMOTO-COMBS, KUMI | reporter.nih.gov |
| IgE Suppressing Berberine Nanomedicine for Treatment of Food Allergies | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $1,814,418 | May 11, 2023 | April 30, 2026 | YANG, NAN | reporter.nih.gov |
| Mechanisms by which intestinal bacteria contribute to maintenance of tolerance in food allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,799,639 | December 24, 2019 | November 30, 2024 | NAGLER, CATHRYN R | reporter.nih.gov |
| Designer covalent heterobivalent inhibitors to prevent IgE-dependent allergic reactions | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,688,300 | December 1, 2014 | July 31, 2025 | BILGICER, ZIHNI BASAR | reporter.nih.gov |
| Epidemiology of multimorbid pediatric atopic and airway diseases and the impact of prenatal maternal environmental exposures and placental epigenetics | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $1,677,190 | September 1, 2023 | May 31, 2025 | STRAUGHEN, JENNIFER K. | reporter.nih.gov |
| Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAb | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,673,474 | July 5, 2019 | June 30, 2025 | FINKELMAN, FRED DOUGLASS | reporter.nih.gov |
| Non-Templated Regulation of IgE Mediated Anaphylaxis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,670,068 | November 16, 2023 | October 31, 2028 | ANTHONY, ROBERT MCCULLOUGH | reporter.nih.gov |
| Gut Microbiome Dynamics in Peanut Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,652,881 | August 6, 2019 | July 31, 2025 | BUNYAVANICH, SUPINDA | reporter.nih.gov |
| Role of gut protists in celiac disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,649,112 | February 8, 2023 | January 31, 2028 | HINTERLEITNER, REINHARD | reporter.nih.gov |
| ATOPIC DERMATITIS RESEARCH NETWORK (ADRN) CLINICAL RESEARCH CENTER | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,648,190 | April 10, 2020 | March 31, 2027 | LEUNG, DONALD YM | reporter.nih.gov |
| Convergent allergen-specific antibodies in food allergy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,644,946 | February 7, 2024 | December 31, 2028 | PATIL, SARITA U | reporter.nih.gov |
| The Role of Food Sensitization in Cardiovascular Disease | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,626,865 | August 13, 2024 | July 31, 2029 | KEET, CORINNE | reporter.nih.gov |
| Pro-Type 2 Goblet Cell Antigen Passages in Food Sensitization and Reactivity | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,623,949 | May 4, 2015 | June 30, 2028 | HOGAN, SIMON PATRICK | reporter.nih.gov |
| Roles of FFAR 3-SCFA axis in Th2 cytokine production by tissuelymphocytes in EoE | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,590,000 | December 1, 2019 | November 30, 2024 | ROTHENBERG, MARC E. | reporter.nih.gov |
| Lysyl oxidase induced esophageal remodeling in eosinophilic esophagitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,568,160 | June 1, 2020 | March 31, 2026 | MUIR, AMANDA BROOKE | reporter.nih.gov |
| TPSAB1-derived tryptases promote myeloproliferation and anaphylaxis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,565,919 | July 1, 2018 | March 31, 2027 | LYONS, JONATHAN | reporter.nih.gov |
| Evaluation of a Behavioral Intervention to Promote Food Allergy Self-Management Among Early Adolescents | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,561,358 | November 1, 2022 | October 31, 2027 | HERBERT, LINDA JONES | reporter.nih.gov |
| Refinement and validation of a symptom report-based food allergy prevalence questionnaire for population-based studies | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,530,922 | September 10, 2025 | August 31, 2029 | GUPTA, RUCHI S | reporter.nih.gov |
| Expecting Mothers' Study of Consumption or Avoidance of Peanut and Egg (ESCAPE) | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $1,522,515 | September 1, 2023 | August 31, 2028 | JARVINEN-SEPPO, KIRSI | reporter.nih.gov |
| Esophageal tissue aging under homeostatic and inflammatory conditions | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,472,309 | June 4, 2019 | March 31, 2024 | WHELAN, KELLY A | reporter.nih.gov |
| Heterogeneity of T cell phenotype and function in food allergy | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $1,464,023 | May 15, 2020 | April 30, 2026 | BERIN, CECILIA | reporter.nih.gov |
| Atopic dermatitis: mechanisms of disease progression | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,439,129 | April 20, 2020 | March 31, 2027 | KHURANA HERSHEY, GURJIT K. | reporter.nih.gov |
| Heterogeneity of T cell phenotype and function in food allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,412,799 | May 15, 2020 | August 15, 2022 | BERIN, CECILIA | reporter.nih.gov |
| Mitochondria in eosinophilic esophagitis pathogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,404,738 | August 15, 2024 | May 31, 2028 | WHELAN, KELLY A | reporter.nih.gov |
| Immune signaling molecules involved in promoting the pathogenesis of eosinophilic esophagitis (EoE) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,389,560 | July 22, 2009 | November 30, 2024 | MISHRA, ANIL | reporter.nih.gov |
| Differential regulation of mast cell-mediated allergic responses by IL-10 | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,345,027 | January 1, 2023 | December 31, 2027 | MATHIAS, CLINTON B | reporter.nih.gov |
| Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,299,441 | June 2, 2025 | May 31, 2028 | PATEL, SAMIRKUMAR | reporter.nih.gov |
| Microneedles for treatment of peanut allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,282,559 | September 17, 2018 | August 31, 2025 | GILL, HARVINDER SINGH | reporter.nih.gov |
| Histamine-Releasing Factor Oligomers in Food Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,268,662 | August 1, 2019 | July 31, 2024 | KAWAKAMI, TOSHIAKI | reporter.nih.gov |
| Exploiting inhibitory Siglecs for desensitizing mast cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,225,338 | September 24, 2018 | August 31, 2023 | PAULSON, JAMES C | reporter.nih.gov |
| Regulation of Gene Expression in the anaphylactic Pathway | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,209,904 | May 15, 2018 | April 30, 2024 | HUANG, HUA | reporter.nih.gov |
| SLC9A3 regulation of esophageal dilated intercellular spaces in EoE Subtypes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,187,668 | April 22, 2019 | March 31, 2023 | HOGAN, SIMON PATRICK | reporter.nih.gov |
| Neuroimmune interactions regulate development of allergic inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,187,423 | November 28, 2023 | October 31, 2028 | KUCHROO, VIJAY K. | reporter.nih.gov |
| Role of epithelial barrier function in food-induced anaphylaxis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,183,923 | April 1, 2023 | March 31, 2028 | PTASCHINSKI, CATHERINE MARY | reporter.nih.gov |
| UNC Food Allergy Initiative | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,138,538 | March 13, 2024 | February 28, 2031 | KIM, EDWIN | reporter.nih.gov |
| Regulation of FcεRI function by the MS4A gene cluster | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,124,878 | September 18, 2019 | August 31, 2025 | CRUSE, GLENN PAUL | reporter.nih.gov |
| University of North Carolina Food Allergy Initiative | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,018,513 | March 1, 2017 | February 29, 2024 | KIM, EDWIN | reporter.nih.gov |
| Systems approach to elucidate the microbiome's influence on the development of food allergies early in life | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $998,240 | December 14, 2020 | November 30, 2025 | MARTIN, VICTORIA MACKENZIE | reporter.nih.gov |
| Arkansas Center for Food Allergy Research (ArCOFAR) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $979,787 | March 14, 2024 | February 28, 2031 | JONES, STACIE M | reporter.nih.gov |
| Function of RELMβ in oral tolerance breakdown in food allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $974,700 | June 9, 2021 | May 31, 2027 | CRESTANI, ELENA | reporter.nih.gov |
| An allergen-specific immune signature-directed diet vs sham diet for treatment of eosinophilic esophagitis: A pilot-feasibility study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $930,539 | April 30, 2022 | March 31, 2026 | DELLON, EVAN SAMUEL | reporter.nih.gov |
| FUNCTIONAL ANALYSIS OF PATHOGENIC AND PROTECTIVE PEANUT ALLERGEN-SPECIFIC HUMAN ANTIBODIES | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $820,742 | February 15, 2017 | January 31, 2024 | BOYD, SCOTT DEXTER | reporter.nih.gov |
| Defining Protective IgGs to Food Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $806,466 | August 1, 2025 | July 31, 2030 | ANTHONY, ROBERT MCCULLOUGH | reporter.nih.gov |
| A role for glycolipids and unconventional T cell subsets in alpha-gal allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $796,034 | June 17, 2020 | May 31, 2026 | IWEALA, ONYINYE I | reporter.nih.gov |
| Patient-Centered Outcomes of the First Approved Peanut Allergy Treatment | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $794,880 | December 8, 2021 | November 30, 2026 | DANTZER, JENNIFER ANNE | reporter.nih.gov |
| Mount Sinai's CoFAR Clinical Research Center | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $789,998 | March 8, 2024 | February 28, 2031 | SICHERER, SCOTT H | reporter.nih.gov |
| Basal Progenitor Cells and Eosinophilic Esophagitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $780,597 | April 1, 2014 | January 31, 2023 | QUE, JIANWEN | reporter.nih.gov |
| Clinical Research Unit: Johns Hopkins University | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $780,000 | April 10, 2024 | February 28, 2031 | WOOD, ROBERT A | reporter.nih.gov |
| Northwestern University CoFAR (NU-CoFAR) Clinical Research Center | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $779,980 | March 11, 2024 | February 28, 2031 | GUPTA, RUCHI S | reporter.nih.gov |
| The role of epithelial barrier dysfunction in food anaphylaxis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $777,600 | July 25, 2022 | June 30, 2027 | SCHULER, CHARLES F | reporter.nih.gov |
| Infant Peanut Allergy Prevention: Understanding and Supporting Caregivers to Achieve Adherence | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $760,320 | July 20, 2022 | June 30, 2027 | SAMADY, WAHEEDA | reporter.nih.gov |
| University of Michigan MHWFAC CoFar CMC Center Application | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $760,000 | March 15, 2024 | February 28, 2031 | BAKER, JAMES R. | reporter.nih.gov |
| Consortium for food allergy research clinical center CoFar | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $760,000 | March 11, 2024 | February 28, 2031 | RACHID, RIMA | reporter.nih.gov |
| Consortium of Food Allergy Research Clinical Research Center at Cincinnati Children's Hospital Medical Center (CoFAR-CRC:CCHMC) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $760,000 | March 1, 2024 | February 28, 2031 | ASSA'AD, AMAL HALIM | reporter.nih.gov |
| Therapeutic and Mechanistic Insights in Food Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $760,000 | March 21, 2024 | February 28, 2031 | SINDHER, SAYANTANI B. | reporter.nih.gov |
| Mechanisms of adverse gastrointestinal events during oral immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $759,456 | July 21, 2022 | June 30, 2027 | WRIGHT, BENJAMIN L. | reporter.nih.gov |
| Molecular details of the IgE antibody response to galactose-alpha-1,3-galactose in alpha-gal syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $753,304 | March 1, 2025 | February 28, 2026 | SMITH, SCOTT ALAN | reporter.nih.gov |
| Epigenetic regulation of esophageal epithelial barrier function in eosinophilic esophagitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $741,312 | January 1, 2020 | February 28, 2025 | RUFFNER, MELANIE A | reporter.nih.gov |
| Less invasive assessment of inflammation and subepithelial remodeling in eosinophilic esophagitis patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $716,240 | August 15, 2018 | June 30, 2024 | TEARNEY, GUILLERMO J | reporter.nih.gov |
| Arkansas Center for Food Allergy Research (ArCOFAR) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $705,000 | March 3, 2017 | February 29, 2024 | JONES, STACIE M | reporter.nih.gov |
| Mount Sinai's COFAR Clinical Research Unit and Clinical Trial (The "ADVANCE" Trial). | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $705,000 | March 5, 2017 | February 29, 2024 | SICHERER, SCOTT H | reporter.nih.gov |
| Evaluating the role of allergen dose and duration in the safety and efficacy of multi-allergen oral immunotherapy with Omalizumab | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $705,000 | March 1, 2017 | February 29, 2024 | CHINTHRAJAH, R. SHARON | reporter.nih.gov |
| Clinical Research Unit: Johns Hopkins University | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $705,000 | March 3, 2017 | February 29, 2024 | WOOD, ROBERT A | reporter.nih.gov |
| National Jewish Health CoFAR Clinical Research Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $704,994 | March 2, 2017 | February 29, 2024 | LEUNG, DONALD YM | reporter.nih.gov |
| Immune progression and plasticity in relation to child age | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $704,953 | March 1, 2017 | February 29, 2024 | SHREFFLER, WAYNE G | reporter.nih.gov |
| T Cell Reagent Research for Monitoring T Cell in Food Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $692,883 | February 7, 2018 | January 13, 2023 | NADEAU, KARI C. | reporter.nih.gov |
| Genetic Regulation of IgE Glycosylation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $690,191 | July 16, 2021 | June 30, 2026 | SORELLE, JEFFREY | reporter.nih.gov |
| Tuft Cell Effector Functions in the Intestine | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $685,646 | February 1, 2020 | February 28, 2030 | VON MOLTKE, JAKOB H. | reporter.nih.gov |
| Development of Mucosal and Systemic Immunity and Risk of Food Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $681,325 | April 1, 2017 | March 31, 2022 | JARVINEN-SEPPO, KIRSI | reporter.nih.gov |
| Multiplex food allergy diagnostic based on IgE immunologic markers | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $644,600 | August 8, 2018 | March 31, 2023 | SEFTEL, DAVID | reporter.nih.gov |
| Early life factors, gene-environment interaction and eosinophilic esophagitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $615,652 | July 1, 2018 | June 30, 2025 | JENSEN, ELIZABETH T | reporter.nih.gov |
| Probing basophil function in microfluidic systems for allergic disease diagnosis | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2023 | $605,019 | August 1, 2021 | May 31, 2024 | TANG, SINDY KAM-YAN | reporter.nih.gov |
| Elucidating the Role of Cutaneous Environmental Factors in the Development of Allergic Disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $584,820 | July 1, 2023 | June 30, 2028 | EISENSTEIN, ANNA | reporter.nih.gov |
| Evaluating the Impact of School Nut-Free Policies | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $583,404 | February 13, 2019 | April 30, 2025 | BARTNIKAS, LISA MARIE | reporter.nih.gov |
| Deciphering the roles of eosinophils and T lymphocytes in EGID | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $572,943 | February 1, 2023 | January 31, 2028 | KUANG, FEI LI | reporter.nih.gov |
| LIGHT/TNFSF14 in allergic esophagitis remodeling | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $568,901 | April 1, 2018 | August 31, 2022 | CROFT, MICHAEL | reporter.nih.gov |
| The control of allergic immune responses by follicular regulatory T cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $534,200 | June 1, 2017 | May 31, 2023 | DENT, ALEXANDER L | reporter.nih.gov |
| Combinatory Effects of Genetic Variants in Eosinophilic Esophagitis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $498,000 | July 1, 2023 | June 30, 2025 | SHODA, TETSUO | reporter.nih.gov |
| IgE Suppressing Berberine Nanomedicine for Treatment of Peanut and Tree nut Allergies | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $490,531 | April 3, 2023 | March 31, 2026 | LI, XIU-MIN | reporter.nih.gov |
| Role of B. infantis in Development of Atopic Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $476,523 | June 16, 2021 | May 31, 2024 | JARVINEN-SEPPO, KIRSI | reporter.nih.gov |
| Esophageal Microbiome, Epithelial Gene Expression, and Response to Topical Swallowed Steroids in Pediatric Eosinophilic Esophagitis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $475,750 | February 1, 2022 | January 31, 2026 | RAJAGOPALA, SEESANDRA VENKATAPPA | reporter.nih.gov |
| Epidemiology of multimorbid pediatric atopic and airway diseases and the impact of prenatal maternal environmental exposures and placental epigenetics | NIH | Office of the Director, National Institutes of Health | 2025 | $466,781 | September 1, 2023 | May 31, 2030 | STRAUGHEN, JENNIFER K. | reporter.nih.gov |
| The Context of Food Allergy Management for Latino Children: Identifying Drivers of Health Disparities | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $464,615 | September 5, 2025 | August 31, 2027 | MCQUAID, ELIZABETH L | reporter.nih.gov |
| Role of Memory IgG B Cells in the Development of Tolerance in Food Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $462,000 | March 24, 2021 | February 28, 2023 | PATIL, SARITA U | reporter.nih.gov |
| Role of maternal Treg cells in the induction of neonatal tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $462,000 | April 15, 2021 | October 31, 2024 | OYOSHI, MICHIKO | reporter.nih.gov |
| Developing RNA Vaccines to Treat Peanut Hypersensitivity | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $461,270 | March 3, 2023 | August 31, 2025 | JOHNSON-WEAVER, BRANDI | reporter.nih.gov |
| Interplay of the T Cell Repertoire Development and Early Life Exposure on Incident Risk of Peanut Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $450,313 | August 3, 2023 | July 31, 2025 | HONG, XIUMEI | reporter.nih.gov |
| Extracellular Vesicles as Biomarkers of Immediate Hypersensitivity Reactions | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $450,313 | June 13, 2024 | April 30, 2026 | DISPENZA, MELANIE C. | reporter.nih.gov |
| High-resolution characterization of human leukocyte antigen genes in diverse populations to study the genetics of food allergy | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $449,999 | September 12, 2022 | August 31, 2024 | WILLIAMS, KEOKI | reporter.nih.gov |
| Virus-Like Particle Based Immunization Against Peanut Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $449,968 | September 22, 2021 | August 31, 2024 | FINN, M.G. | reporter.nih.gov |
| The Role of Social, Economic and Environmental Factors in Food Allergy Disparities | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $448,487 | November 1, 2021 | October 31, 2025 | BILAVER, LUCY A | reporter.nih.gov |
| The adaptive immune response to food antigens in the gut | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $448,000 | August 20, 2021 | July 31, 2023 | EISENBARTH, STEPHANIE CAROLINE | reporter.nih.gov |
| Investigation of the prevalence, presentation and immunologic features of the α-Gal syndrome in a high-risk cohort not recruited on the basis of allergic disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $444,125 | July 22, 2022 | June 30, 2025 | WILSON, JEFFREY M | reporter.nih.gov |
| Genetic ancestry differences in IgE- mediated peanut allergy in African Americans | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $437,250 | June 1, 2021 | May 31, 2024 | MERSHA, TESFAYE B. | reporter.nih.gov |
| Supramolecular peptide immunotherapies for peanut allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $435,093 | June 2, 2021 | May 31, 2024 | COLLIER, JOEL H | reporter.nih.gov |
| Discovery and engineering of novel anti-IgE disruptive inhibitors | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $432,850 | September 24, 2021 | August 31, 2023 | JARDETZKY, THEODORE S | reporter.nih.gov |
| Exploring the Ethical Dimensions of Peanut Allergy Immunotherapy Research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $427,625 | December 1, 2020 | November 30, 2023 | FISHER, JILL A | reporter.nih.gov |
| Metabolomics of Food Allergen Immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $427,625 | June 3, 2024 | April 30, 2027 | VIRKUD, YAMINI V | reporter.nih.gov |
| Relationship of Immune Responses to Clinical Phenotype and Familial Risk in Eosinophilic Gastroenteritis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $423,500 | August 15, 2023 | July 31, 2025 | PETERSON, KATHRYN A | reporter.nih.gov |
| TFH cell programming for IgE responses | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $420,131 | March 10, 2023 | February 28, 2026 | DENT, ALEXANDER L | reporter.nih.gov |
| Exploiting Siglec-6 for targeted anti-allergy drug delivery into human mast cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $417,393 | March 8, 2021 | August 31, 2023 | BOCHNER, BRUCE S | reporter.nih.gov |
| Dysregulated sensing of invertebrate tropomyosin through dectin-1 confers susceptibility to type-2-mediated allergic diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $409,375 | June 1, 2017 | May 31, 2023 | LAJOIE, STEPHANE | reporter.nih.gov |
| GUT SPECIFIC AND TIME-LIMITED EVENTS IN EARLY LIFE PROMOTING TOLERANCE | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $406,057 | March 15, 2017 | February 28, 2022 | NEWBERRY, RODNEY D | reporter.nih.gov |
| Induction of food allergen-specific neonatal tolerance through breast milk | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $405,567 | December 1, 2018 | November 30, 2024 | OYOSHI, MICHIKO | reporter.nih.gov |
| Revealing the mechanisms of increased intestinal epithelial cell barrier permeability in peanut allergy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $404,628 | August 15, 2024 | July 31, 2029 | STEINBACH, ERIN C. | reporter.nih.gov |
| The impact of exposure to allergic inflammation on esophageal carcinogenesis | NIH | National Cancer Institute | 2021 to 2022 | $403,839 | December 1, 2020 | November 30, 2022 | WHELAN, KELLY A | reporter.nih.gov |
| Regulation of T cell responses to oral antigens | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $402,500 | January 11, 2017 | December 31, 2022 | CHOI, YONGWON | reporter.nih.gov |
| Endophenotypes of food allergy in response to oral immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $401,760 | September 1, 2018 | August 31, 2024 | VIRKUD, YAMINI V | reporter.nih.gov |
| Th9 cells in immediate hypersensitivity | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $393,750 | January 1, 2017 | December 31, 2022 | KAPLAN, MARK H | reporter.nih.gov |
| Effects of IgE Blockade on T Cells in Food Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $392,500 | July 16, 2018 | June 30, 2022 | NADEAU, KARI C. | reporter.nih.gov |
| Hormones in allergic disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $392,333 | December 7, 2016 | November 30, 2022 | BERDNIKOVS, SERGEJS | reporter.nih.gov |
| Eosinophil functions in allergic gastrointestinal diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $388,750 | November 1, 2018 | February 28, 2023 | SPENCER, LISA ANN | reporter.nih.gov |
| Improving Anaphylaxis Outcomes Through Personalized Care Strategies | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $384,504 | February 20, 2024 | January 31, 2029 | DRIBIN, TIMOTHY ERICK | reporter.nih.gov |
| Role of gut protists in celiac disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $378,000 | August 15, 2022 | January 31, 2023 | HINTERLEITNER, REINHARD | reporter.nih.gov |
| Mentoring Patient Oriented Research in Allergic Eosinophilic Gastrointestinal Disorders | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $359,096 | December 12, 2017 | November 30, 2022 | ACEVES, SEEMA S | reporter.nih.gov |
| Optimizing Equitable Peanut Allergy Prevention among Infants at High Risk of Peanut Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $357,955 | August 20, 2024 | July 31, 2028 | FLOM, JULIE | reporter.nih.gov |
| B Cell Mechanisms of Tolerance Following Infant Peanut Consumption | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $357,944 | August 1, 2020 | May 30, 2023 | LIN, ADORA A | reporter.nih.gov |
| IL-9-producing MC precursor ancestry and function in Food Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $330,000 | April 1, 2023 | March 31, 2024 | HOGAN, SIMON PATRICK | reporter.nih.gov |
| Safety and Tolerability of Shrimp Oral Immunotherapy in Shrimp Allergic Subjects | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $312,632 | April 15, 2021 | March 31, 2023 | DAVIS, CARLA M. | reporter.nih.gov |
| Understanding IgE Biology | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $300,000 | July 1, 2021 | March 9, 2022 | WESEMANN, DUANE R. | reporter.nih.gov |
| Anti-eosinophil Gene Therapy for Eosinophilic Esophagitis | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $300,000 | May 6, 2022 | April 30, 2024 | CRYSTAL, RONALD G | reporter.nih.gov |
| Chimeric antigen receptor (CAR) T cell therapy for severe allergic diseases. | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $300,000 | January 5, 2024 | December 31, 2025 | MA, ZHENGYU | reporter.nih.gov |
| Bispecific antibody targeting IgE-producing B cells for treating allergic diseases | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $300,000 | February 1, 2025 | January 31, 2027 | MA, ZHENGYU | reporter.nih.gov |
| IgE-suppressing small molecule compound Xanthopurpurin analog for multiple food allergies | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $289,622 | July 12, 2023 | June 30, 2025 | LI, XIU-MIN | reporter.nih.gov |
| Cell-cell interactions driving gut inflammation and tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $279,342 | August 1, 2023 | July 31, 2025 | CAMPOS CANESSO, MARIA CECILIA | reporter.nih.gov |
| Combinatory Effects of Genetic Variants in Eosinophilic Esophagitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $260,666 | August 2, 2021 | June 30, 2023 | SHODA, TETSUO | reporter.nih.gov |
| mRNA vaccination targeting Amblyomma ticks to prevent alpha gal syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $251,250 | February 1, 2025 | January 31, 2027 | NARASIMHAN, SUKANYA | reporter.nih.gov |
| Immunological niche to analyze progression and heterogeneity of allergic disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $250,000 | August 21, 2025 | July 31, 2026 | SHEA, LONNIE D | reporter.nih.gov |
| Cell-cell interactions driving gut inflammation and tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $249,000 | August 1, 2023 | August 31, 2027 | CAMPOS CANESSO, MARIA CECILIA | reporter.nih.gov |
| Understanding the Role of Tick Phospholipase A2 in Alpha-Gal Syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $235,822 | July 23, 2025 | June 30, 2027 | KARIM, SHAHID | reporter.nih.gov |
| The Role of the GPR15-C10ORF99 Pathway in T cell Homing during Eosinophilic Esophagitis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $226,980 | February 1, 2025 | January 31, 2027 | KIM, SANGWON VINCENT | reporter.nih.gov |
| Maternal and Cord Blood Metabolome, Infant Feeding, and Development of Food Allergy in a Prospective Birth Cohort | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $204,688 | July 1, 2020 | June 30, 2023 | HONG, XIUMEI | reporter.nih.gov |
| Skin-associated B cells in allergy | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $201,875 | February 1, 2020 | July 31, 2022 | ERICKSON, LOREN D | reporter.nih.gov |
| IgE-Independent Mast Cell Activation by Food-Derived Peptides in Eosinophilic Esophagitis (EoE) | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $201,875 | March 1, 2020 | February 28, 2023 | MCGOWAN, EMILY CLARKE | reporter.nih.gov |
| Contribution of rigid matrix to allergic eosinophilic esophagitis pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $197,500 | July 1, 2011 | March 31, 2025 | ACEVES, SEEMA S | reporter.nih.gov |
| Probing the Mechanisms of Fibroblast-Extracellular Matrix Interactions to Assess Disease Severity in Allergic Eosinophilic Esophagitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $197,396 | May 22, 2020 | April 30, 2023 | ACEVES, SEEMA S | reporter.nih.gov |
| Developing an Intervention to Promote Early Introduction of Peanut and Egg to Reduce Food Allergy Risk | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $195,696 | August 1, 2025 | July 31, 2029 | CUSHMAN, GRACE | reporter.nih.gov |
| Eosinophil functions in allergic gastrointestinal diseases | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $195,000 | May 10, 2024 | April 30, 2025 | SPENCER, LISA ANN | reporter.nih.gov |
| The pig: A novel large animal model of allergic eosinophilic esophagitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $194,280 | February 1, 2020 | January 31, 2023 | KAESER, TOBIAS E | reporter.nih.gov |
| Molecular basis for anaphylaxis due to galactose-alpha-1,3-galactose (alpha-gal) | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $187,027 | June 2, 2020 | May 31, 2024 | SMITH, SCOTT ALAN | reporter.nih.gov |
| An Integrated Micro-Basophil Activation Test for Rapid Food Allergy Diagnostics | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $184,973 | April 1, 2020 | March 31, 2023 | TANG, SINDY KAM-YAN | reporter.nih.gov |
| Dietary Impacts to Microbial Composition and Function in Eosinophilic Esophagitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $183,600 | July 15, 2025 | May 31, 2030 | UCHIDA, AMIKO | reporter.nih.gov |
| The Role of FOXM1 in Eosinophilic Esophagitis Pathogenesis | NIH | National Center for Advancing Translational Sciences | 2023 | $178,000 | August 1, 2023 | July 31, 2025 | MUIR, AMANDA BROOKE | reporter.nih.gov |
| TGFβ Restricts Tfh2 Differentiation but Augments IgE-Mediated Mast Cell Function: Critical and Opposing Roles in Allergic Disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $162,000 | June 18, 2025 | May 31, 2027 | HAQUE, TAMARA TASMIA | reporter.nih.gov |
| A pilot study to define maintained alterations in mitochondrial DNA of eosinophilic esophagitis patients that may be exploited clinically | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $158,500 | November 30, 2020 | October 31, 2023 | WHELAN, KELLY A | reporter.nih.gov |
| Characterizing and optimizing IgE and IgG4 microarray peptide assays for Ara h 2 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $155,500 | July 7, 2021 | June 30, 2024 | DRESKIN, STEPHEN C | reporter.nih.gov |
| RNA Sequencing if Esophageal Tissues During Food Elimination and Reintroduction Reveals Novel Findings Regarding the Early Pathogenesis of EoE | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $153,799 | August 12, 2025 | July 31, 2027 | PETERSON, KATHRYN A | reporter.nih.gov |
| Modeling and prediction of allergic trajectories in children | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $151,444 | December 4, 2024 | November 30, 2029 | GABRYSZEWSKI, STANISLAW J | reporter.nih.gov |
| Sex difference in conjunctival epithelial cell response and their profile of extracellular bioactive lipids duringallergic inflammation | NIH | National Eye Institute | 2023 to 2024 | $146,256 | September 1, 2023 | August 31, 2025 | LEE, CHANGRIM | reporter.nih.gov |
| Challenging Allergies: The Search for a Magic Bullet for Pediatric Food Allergies | NIH | National Library of Medicine | 2023 to 2025 | $145,132 | July 12, 2023 | June 30, 2026 | FISHER, JILL A | reporter.nih.gov |
| Preventing Peanut Allergy in Young Children: Identifying Barriers to Protocol Engagement and Adherence | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $141,270 | July 12, 2022 | July 11, 2024 | CUSHMAN, GRACE | reporter.nih.gov |
| Characterizing the IgG1 Memory B cells that are precursors of pathogenic IgE | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $140,060 | August 3, 2022 | August 2, 2025 | REDES, JAMIE | reporter.nih.gov |
| Mast cell regulation of food allergen induced malaise through GDF15-GFRAL signaling | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $121,042 | January 1, 2023 | December 31, 2025 | BACHTEL, NATHANIEL DALE | reporter.nih.gov |
| Tissue remodeling in Eosinophilic Esophagitis: Discovery of novel pathways | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $116,625 | July 10, 2020 | April 30, 2023 | MENARD-KATCHER, CALIES D | reporter.nih.gov |
| Molecular and epigenetic predictors and mechanisms of treatment response to topical steroids in eosinophilic esophagitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $116,505 | April 27, 2020 | March 31, 2024 | DELLON, EVAN SAMUEL | reporter.nih.gov |
| DEVELOPMENT OF NANOVAX TM (OIL IN WATER NANOEMULSION ADJUVANT) FORMULATED ALLERGENS AS INTRANASAL IMMUNOTHERAPEUTIC VACCINES FOR PEANUT ALLERGY. | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $79,300 | September 1, 2020 | August 31, 2024 | FATTOM, ALI I. | reporter.nih.gov |
| Detection of Food Allergens in Human Milk | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $77,000 | March 1, 2020 | November 30, 2022 | SEPPO, ANTTI | reporter.nih.gov |
| The role of bitter taste sensing in food allergies | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $74,958 | January 1, 2020 | December 31, 2021 | KHOURY-HANOLD, WILLIAM | reporter.nih.gov |
| Structural and molecular markers for detection and monitoring of pediatric fibrostenotic Eosinophilic Esophagitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $69,120 | September 12, 2016 | January 31, 2023 | MENARD-KATCHER, CALIES D | reporter.nih.gov |
| Triggers of food allergen absorption and anaphylaxis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $53,461 | November 1, 2025 | October 31, 2028 | JACOBSEN, DANIELLE ROSE | reporter.nih.gov |
| Microbiota regulation of intestinal eosinophils | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $52,568 | December 1, 2019 | May 31, 2022 | CAO, YIYUN GRACE | reporter.nih.gov |
| Assessing food-specific tolerogenic CD4+ T cells in protection from food allergy | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $49,538 | May 1, 2025 | April 30, 2027 | MASUDA, MIA Y. | reporter.nih.gov |
| Dissecting an IL4Ra-dependent neuroimmune circuit in eosinophilic esophagitis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $42,479 | August 17, 2025 | August 16, 2029 | KELLERMAN, KENDALL | reporter.nih.gov |
| IL-13-induced SFRP1 requires STAT3 to regulate esophageal epithelial proliferation and Basal Zone Hyperplasia in EoE | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $37,047 | March 1, 2023 | January 14, 2024 | MARELLA, SAHITI | reporter.nih.gov |
| Understanding eosinophilic esophagitis-mediated inhibition of esophageal cancer | NIH | National Cancer Institute | 2025 | $36,264 | September 1, 2025 | August 31, 2027 | FULLER, ANNE | reporter.nih.gov |
| Mechanisms and functional role of mitochondria in eosinophilic esophagitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 | $35,422 | August 1, 2024 | April 25, 2025 | JACKSON, JAZMYNE | reporter.nih.gov |
| 2024 Food Allergy Gordon Research Conference & Gordon Research Seminar | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $20,000 | December 1, 2023 | November 30, 2024 | EISENBARTH, STEPHANIE CAROLINE | reporter.nih.gov |
| 2022 Food Allergy Gordon Research Conference and Seminar | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $10,000 | July 1, 2021 | June 30, 2022 | BERIN, CECILIA | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Johns Hopkins University | Baltimore, MD | 9 | $32.9 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 8 | $22.3 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 11 | $17.6 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 8 | $15.2 million | 0 | $0 |
| Stanford University | Stanford, CA | 11 | $12.9 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 11 | $12.5 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 13 | $12 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 9 | $9.3 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 2 | $9 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 9 | $8.1 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 5 | $7.8 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 5 | $7.5 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 5 | $7.5 million | 0 | $0 |
| Lurie Children's Hospital of Chicago | Chicago, IL | 3 | $7.2 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 1 | $6.5 million | 0 | $0 |
| National Jewish Health | Denver, CO | 4 | $6.4 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 5 | $6 million | 0 | $0 |
| Moonlight Therapeutics, Inc. | Marietta, GA | 3 | $5.1 million | 0 | $0 |
| Yale University | New Haven, CT | 7 | $4.7 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 6 | $4.3 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 5 | $4.1 million | 0 | $0 |
| Washington University | Saint Louis, MO | 2 | $3.6 million | 0 | $0 |
| Mayo Clinic Arizona | Scottsdale, AZ | 3 | $3.5 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 6 | $3.5 million | 0 | $0 |
| Rockefeller University | New York, NY | 2 | $3.2 million | 0 | $0 |
| Siolta Therapeutics, Inc. | San Carlos, CA | 1 | $2.9 million | 0 | $0 |
| University of Rochester | Rochester, NY | 4 | $2.8 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 2 | $2.7 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 2 | $2.7 million | 0 | $0 |
| General Nutraceutical Technology, LLC | Briarcliff Manor, NY | 3 | $2.6 million | 0 | $0 |
| Henry Ford Health System | Detroit, MI | 3 | $2.6 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 1 | $2.3 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 2 | $2 million | 0 | $0 |
| Wayne State University | Detroit, MI | 1 | $1.9 million | 0 | $0 |
| Children's Research Institute | Washington, DC | 2 | $1.9 million | 0 | $0 |
| Secretory Iga, Inc. | Ann Arbor, MI | 1 | $1.9 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 1 | $1.8 million | 0 | $0 |
| La Jolla Institute for Immunology | La Jolla, CA | 2 | $1.8 million | 0 | $0 |
| University of North Dakota Main Campus | Grand Forks, ND | 1 | $1.8 million | 0 | $0 |
| University of Chicago | Chicago, IL | 1 | $1.8 million | 0 | $0 |
| University of Notre Dame | Notre Dame, IN | 1 | $1.7 million | 0 | $0 |
| Arkansas Children's Hospital Res Inst | Little Rock, AR | 2 | $1.7 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 1 | $1.7 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 2 | $1.5 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 1 | $1.4 million | 0 | $0 |
| University of Connecticut | Storrs, CT | 1 | $1.3 million | 0 | $0 |
| North Carolina State University | Raleigh, NC | 2 | $1.3 million | 0 | $0 |
| Texas Tech University | Lubbock, TX | 1 | $1.3 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 1 | $1.2 million | 0 | $0 |
| Duke University | Durham, NC | 2 | $896,363 | 0 | $0 |
| Rhode Island Hospital | Providence, RI | 3 | $801,581 | 0 | $0 |
| University of Utah | Salt Lake City, UT | 3 | $760,899 | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 1 | $690,191 | 0 | $0 |
| University of Washington | Seattle, WA | 1 | $685,646 | 0 | $0 |
| Enable Biosciences, Inc. | South San Francisco, CA | 1 | $644,600 | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 1 | $615,652 | 0 | $0 |
| Cellergy Pharma | Wilmington, DE | 2 | $600,000 | 0 | $0 |
| Georgia Tech Research Corporation | Atlanta, GA | 1 | $449,968 | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 1 | $312,632 | 0 | $0 |
| Enyx Therapeutics, LLC | New York, NY | 1 | $300,000 | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 1 | $249,000 | 0 | $0 |
| University of Southern Mississippi | Hattiesburg, MS | 1 | $235,822 | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 1 | $226,980 | 0 | $0 |
| Schepens Eye Research Institute | Boston, MA | 1 | $146,256 | 0 | $0 |
| Bluewillow Biologics, Inc. | Ann Arbor, MI | 1 | $79,300 | 0 | $0 |
| Harvard Medical School | Boston, MA | 1 | $52,568 | 0 | $0 |
| Gordon Research Conferences | East Greenwich, RI | 2 | $30,000 | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 97 | $78,054,253 | 0 | $0 |
| 2024 | 102 | $68,211,408 | 0 | $0 |
| 2023 | 100 | $49,878,784 | 0 | $0 |
| 2022 | 99 | $45,870,746 | 0 | $0 |
| 2021 | 107 | $45,225,869 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | May 7, 2027 | Not listed | Notice number printed on 2 awards here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 184 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 184 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 184 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 184 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 184 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 184 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 184 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 184 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 184 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 184 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 184 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 184 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 184 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 184 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 184 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 184 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 184 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 184 awards here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 184 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.